Publications
- Mezinárodní randomizovaná studie primární léčby nemocných mladších 60ti let s difusním velkobuněčným B-lymfomem (DLBCL) s nízkým a středně nízkým rizikem srovnávající CHOP-like režim s rituximabem nebo bez rituximabu, první interim analýzaPublication without faculty affiliation
- Cell Dysplasia - Cell Dysplastic Features (A Morphological Note)2023 | First Faculty of Medicine
- The Reduction of the Cell Nuclear Size in the Cell Body Space During the Differentiation Might Be Cell Lineage Specific (A Retrospective Morphological Note)2023 | First Faculty of Medicine
- Polatuzumab vedotin plus bendamustine and rituximab in patients with relapsed/refractory diffuse large B-cell lymphoma in the real world2022 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Third Faculty of Medicine, Faculty of Medicine in Pilsen
- RNA Concentration and Content in the Nucleoli and Cytoplasmic Rim in Differentiating Lymphocytes of Patients Suffering from B Chronic Lymphocytic Leukaemia - a Cytochemical Note2022 | First Faculty of Medicine
- CD31/PECAM-1 impacts engraftment, growth and spread of mantle cell lymphoma cells and positively correlates with extramedullary involvement2021 | First Faculty of Medicine
- The Cell Body Space Occupied by the Nucleus During the Cell Differentiation in Human Lymphocytic, Granulocytic and Erythroid Cell Lineages2021 | First Faculty of Medicine
- Prospective observational study in comorbid patients with chronic lymphocytic leukemia receiving first-line bendamustine with rituximab2019 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- 18F-FDG PET/CT pattern of Erdheim-Chester disease - a group of Czech patients2018 | First Faculty of Medicine
- Ofatumumab added to dexamethasone in patients with relapsed or refractory chronic lymphocytic leukemia: Results from a phase II study2015 | Faculty of Medicine in Hradec Králové
Loading network view...